Short-Term Evolution and Dispersal Patterns of fluconazole-resistance in Candida auris clade III
Irving Cancino‐MuñoziD, Juan Vicente Mulet BayonaiD, Carme Salvador GarcíaiD, Nuria TormoiD, Remedios Guna, Concepción Gimeno CardonaiD, Fernando Gónzález‐CandelasiD
Abstract
The rapid increase of infections caused by the emerging fungal pathogen Candida auris is of global concern, and understanding its expansion is a priority. The phylogenetic diversity of the yeast is clustered in five major clades, among which clade III is particularly relevant, as most of its strains exhibit resistance to fluconazole, reducing the therapeutic alternatives and provoking outbreaks that are difficult to control. In this study, we have investigated the phylogenetic structure of clade III by analyzing a global collection of 566 genomes. We have identified three subgroups within clade III, among which two are genetically most closely related. Moreover, we have estimated the evolutionary rate of clade III to be 2.25e-7 s/s/y (2.87 changes per year). We found that one of these subgroups shows intrinsic resistance to fluconazole and is responsible for the majority of cases within this clade globally. We inferred that this subgroup may have originated around December 2010 (95% HPD: April 2010 - June 2011), and since then it has spread across continents, generating multiple large outbreaks, each with a unique pattern of transmission and dissemination. These results highlight the remarkable ability of the pathogen to adapt to its environment and its rapid global spread, underscoring the urgent need to effectively address this epidemiological challenge. IMPORTANCEThe number of cases affected by Candida auris has increased worryingly worldwide. Among the currently recognized clades, clade III has the highest proportion of fluconazole-resistant cases and is spreading very rapidly, causing large nosocomial outbreaks across the globe. By analyzing complete fungal genomes from around the world, we have confirmed the origin of this clade and unraveled its dispersal patterns in the early 2010s. This finding provides knowledge that may be helpful to the public health authorities for the control of the disease.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 2.46
- Field percentile
- top 10%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses
Nancy A. Chow, José Fernando Muñoz, … Christina A. Cuomo·mBioPeer-reviewed·Apr 27, 2020
- Genomic diversity across Candida auris clinical isolates shapes rapid development of antifungal resistance in vitro and in vivo
L. S. Burrack, R. T. Todd, … A. Selmecki·bioRxiv·Mar 25, 2022
- Genomic epidemiology and antifungal-resistant characterization of Candida auris, Colombia, 2016-2021
Elizabeth Misas, Patricia Escandón, … Nancy A. Chow·mSpherePeer-reviewed·Feb 1, 2024
- Genotypic and phenotypic characterization of a nosocomial outbreak of Candida auris in Spain during five years
Juan Vicente Mulet Bayona, Irving Cancino‐Muñoz, … Concepción Gimeno-Cardona·MycosesPeer-reviewed·Jul 31, 2024
- Relative contributions of the ERG11VF125AL and MRR1AN647T mutations to fluconazole resistance in Clade III Candidozyma (Candida) auris clinical isolates
Katherine S. Barker, Qing Hua Zhang, … David Rogers·bioRxiv·Mar 31, 2025
- Genomic epidemiology of Candida auris introduction and outbreaks in the United Kingdom
Dana Kappel, Hugh Gifford, … Johanna L. Rhodes·bioRxiv·Jan 15, 2024